New antibiotic cocktail takes on deadly hospital pneumonia
NCT ID NCT07327619
First seen Jan 11, 2026 · Last updated May 10, 2026 · Updated 22 times
Summary
This study tests a new antibiotic combination (meropenem and pralurbactam) against a standard treatment for serious lung infections caught in the hospital or from a breathing machine. About 420 adults aged 18 to 80 will take part. The goal is to see if the new drug works just as well and is safe, with a focus on survival at 14 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hunan University Of Medicine General Hospital
RECRUITINGHuaihua, Hunan, 418000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.